Hyperthermia in oncology

International Journal of Hyperthermia

Volumn 17, Issue 1, 2001, Pages 1-18

  Falk, M H ^a   Issels, R D ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

Clinical trials; Combined treatment modalities; Hyperthermia; Thermobiology

Indexed keywords

BLEOMYCIN; CISPLATIN; DOXORUBICIN; ETOPOSIDE; FLUOROURACIL; IFOSFAMIDE; MELPHALAN; MITOMYCIN; MITOMYCIN C;

BREAST CANCER; CANCER COMBINATION CHEMOTHERAPY; CANCER CONTROL; CANCER SURVIVAL; CHILD; CLINICAL TRIAL; DIGESTIVE SYSTEM CANCER; GLIOBLASTOMA; HEAD AND NECK CANCER; HUMAN; HYPERTHERMIC THERAPY; IONIZING RADIATION; MELANOMA; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; PHASE 3 CLINICAL TRIAL; REVIEW; SARCOMA; TREATMENT OUTCOME; TUMOR; UROGENITAL TRACT CANCER;

EID: 0035176942     PISSN: 02656736     EISSN: None     Source Type: Journal    
DOI: 10.1080/02656730150201552     Document Type: Review

References (64)

1. Cisplatin, hyperthermia, and radiation (trimodal therapy) in patients with locally advanced head and neck tumors: A phase I-II study
2. Prognostic indicators in patients with isolated local-regional recurrence of breast cancer
3. Local hyperthermia, radiation therapy, and chemotherapy in patients with local-regional recurrence of breast carcinoma
4. Magnetic resonance thermometry during hyperthermia for human high-grade sarcoma
5. Head and neck cancers: Results of thermoradiotherapy versus radiotherapy
6. Arrhenius relationships from the molecule and cell to the clinic
7. Combined treatment of inoperable carcinomas of the uterine cervix with radiotherapy and regional hyperthermia. Results of a phase II trial
8. Isolated limb perfusion with high-dose tumor necrosis factor-α in combination with interferon-γ and melphalan for nonresectable extremity soft tissue sarcomas: A multicenter trial
9. Phase III study of interstitial thermoradiotherapy compared with interstitial radiotherapy alone in the treatment of recurrent or persistent human tumors: A prospectively controlled randomized study by the radiation therapy oncology group
10. Combination therapy for resectable and unresectable adenocarcinoma of the pancreas
11. Deep regional hyperthermia: Comparison between the annular phased array and the sigma-60 applicator in the same patients
12. Refinement of clinicopathologic staging for localized soft tissue sarcoma of the extremity: A study of 423 adults
13. Hyperthermic perfusion with chemotherapy for melanoma of the extremities
14. Combined treatment with radiation and hyperthermia in metastatic malignant melanoma
15. Regional hyperthermic perfusion with melphalan after surgery for recurrent malignant melanoma of the extremities
16. A review of microwave and RF applicators for localised hyperthermia
17. Improved survival and local control after total mesorectal excision or D3 lymphadenectomy in the treatment of primary rectal cancer: An international analysis of 1411 patients
18. Thermo-chemo-radiotherapy of esophageal cancer, a preliminary report on 34 cases
19. Soft tissue sarcomas - What is currently being done
20. Neoadjuvant chemotherapy combined with regional hyperthermia (RHT) followed by surgery and radiation in primary and recurrent high-risk soft tissue sarcomas (HR-STS) of adults (updated report)
21. Preoperative systemic etoposide/ifosfamide/doxorubicin chemotherapy combined with regional hyperthermia in high-risk sarcoma: A pilot study
22. Improvement of local control by regional hyperthermia combined with systemic chemotherapy (ifosfamide plus etoposide) in advanced sarcomas: Updated report on 65 patients
23. Ifosfamide plus etoposide combined with regional hyperthermia in patients with locally advanced sarcomas: A phase II study
24. Multi-institutional clinical studies on hyperthermia combined with radiotherapy or chemotherapy in advanced cancer of deep-seated organs
25. Combination hyperthermia and radiation therapy for malignant melanoma
26. The clinical and histopathological contributing factors influencing the effectiveness of preoperative hyperthermo-chemo-radiotherapy for the patients with esophageal cancer
27. Prophylactic isolated limb perfusion for localized, high-risk limb melanoma: Results of a multicenter randomized phase III trial
28. Preoperative hyperthermia and radiation for soft tissue sarcomas: Advantage of two vs one hyperthermia treatments per week
29. A preliminary report on the treatment of esophageal cancer by intraluminal microwace hyperthermia and chemotherapy
30. Hyperthermic oncology: Current biology, physics and clinical results
31. Improved surgical results after combining preoperative hyperthermia with chemotherapy and radiotherapy for patients with carcinoma of the rectum
32. Sensitivity of hyperthermia trial outcomes to temperature and time: Implications for thermal goals of treatment
33. The current and potential role of hyperthermia in radiotherapy
34. Randomised trial of hyperthermia as adjuvant to radiotherapy for recurrent or metastatic malignant melanoma
35. Systemic hyperthermia by extracorporal induction: Techniques and results
36. Quality assurance problems in clinical hyperthermia and their impact on therapeutic outcome. A report by the Radiation Therapy Oncology Group
37. Randomized phase III study comparing irradiation and hyperthermia with irradiation alone in superficial measurable tumors
38. The treatment of high-grade soft tissue sarcomas with preoperative thermoradiotherapy
39. Preoperative hyperthermia combined with radiochemotherapy in locally advanced rectal cancer. A phase II clinical trial
40. Phase II trial of weekly locoregional hyperthermia and cisplatin in patients with a previously irradiated recurrent carcinoma of the uterine cervix
41. A phase I clinical study of carboplatin and 41.8°C whole body hyperthermia in cancer patients
42. Phase I clinical trial of melphalan and 41.8°C whole-body hyperthermia in cancer patients
43. A new technological approach to radiant heat whole body hyperthermia
44. Regionale hyperthermie mit systemischer chemotherapie bei kindern und jugendlichen: Durchführbarkeit und klinische verläufe bei 34 intensiv vorbehandelten patienten mit prognostisch ungünstigen tumorerkrankungen
45. Cancer of the esophagus
46. Clinical practice of interstitial thermoradiotherapy
47. Clinical experience with interstitial thermoradiotherapy for localized head and neck tumors
48. Relationship between thermal dose and outcome in thermoradiotherapy treatments for superficial recurrences of breast cancer: Data from a phase III trial
49. Intraoperative radiotherapy and hyperthermia for unresectable pancreatic cancer
50. Survival benefit of hyperthermia in a prospective randomized trial of brachytherapy boost (hyperthermia for glioblastoma multiforme
51. Hyperthermia combined with chemotherapy and irradiation for patients with carcinoma of the oesophagus - A prospective randomized trial
52. Chemotherapy combined with or without hyperthermia for patients with oesophageal carcinoma: A prospective randomized trial
53. Clinical outcome of intraoperative pelvic hyperthermochemotherapy for patients with Dukes' C rectal cancer
54. Improved treatment for cervical cancer - Concurrent chemotherapy and radiotherapy
55. Preoperative hyperthermochemoradiotherapy for patients with esophageal carcinoma or rectal carcinoma
56. For the clinical application of thermochemotherapy given at mild temperatures
57. Report of long-term follow-up in a randomized trial comparing radiation therapy and radiation therapy plus hyperthermia to metastatic lymphnodes in stage IV head and neck patients
58. 3 (TNM-UICC) neck nodes: A prospective randomized clinical trial
59. Comparison of radiotherapy alone with radiotherapy plus hyperthermia in locally advanced pelvic tumours: A prospective, randomised, multicentre trial. Dutch Deep Hyperthermia Group
60. Radiotherapy with or without hyperthermia in the treatment of superficial localized breast cancer: Results from five randomized controlled trials
61. Hyperthermia for the treatment of patients with malignant germ cell tumors. A phase I/II study in ten children and adolescents with recurrent or refractory tumors
62. Ifosfamide and carboplatin combined with 41.8°C whole-body hyperthermia in patients with refractory sarcoma and malignant teratoma
63. Ifosfamide, carboplatin, and etoposide (ICE) combined with 41.8°C whole-body hyperthermia in patients with refractory sarcoma
64. Rationale for using invasive thermometry for regional hyperthermia of pelvic tumors